TrialSignal
Clinical trial intelligence report
Effect of Cryopreservation on SARS-CoV-2 Semen Samples: Influence of Two Different Cryopreservation Procedures Evaluated After Thawing
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06703723-Jul 28, 2026
NCT ID
NCT06703723
Status
COMPLETED
Phase
Completed (Observational Study)
Sponsor
Istituto Clinico Humanitas
Executive brief
Investment-Ready Snapshot
The study conducted by Istituto Clinico Humanitas addresses a critical gap in understanding the impact of SARS-CoV-2 on male reproductive health, particularly in the context of cryopreservation of semen. Given the increasing focus on fertility preservation amid the pandemic, this research could lead to the development of new protocols for semen cryopreservation that mitigate viral contamination risks. The findings may have significant implications for reproductive medicine and fertility clinics, potentially enhancing market offerings in fertility preservation services. Furthermore, the results could inform regulatory considerations and guidelines for handling biological samples in the context of viral infections, impacting competitive positioning in the reproductive health sector.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06703723
Indication
COVID 19
Modality
RNA therapy
Target
ACE2 and TMPRSS2 receptors on spermatozoa
Intervention
Not reported
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.